Evaluating the Impact of Automated Evaluation of Gastrointestinal Symptoms (AEGIS) on Clinical Outcomes
NCT02530216 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 610
Last updated 2018-05-01
Summary
Healthcare delivery now mandates shorter visits with higher documentation requirements, undermining the patient-provider interaction. Electronic health records (EHRs) have the potential to improve outcomes and quality of care in this pressured environment, and are endorsed by the Patient Protection and Affordable Care Act (ACA) and Health Information Technology for Economic and Clinical Health (HITECH) Act as an important mechanism to support value-based healthcare. However, EHR systems were principally designed to support the transactional needs of administrators and billers, less so to nurture the relationship between patients and their providers. The purpose of this research is to identify ways to use EHRs to support clinical gastroenterologists and their patients while meeting the meaningful use requirements of the HITECH Act.
To improve clinic visit efficiency and meet criteria for meaningful use, investigators developed a patient-provider portal (P3) that systematically collects patient symptoms using a computer algorithm called Automated Evaluation of Gastrointestinal Symptoms (AEGIS). AEGIS utilizes computerized adaptive testing (CAT) to guide patients through questions drawn from a library of over 300 symptom attributes measuring the timing, severity, frequency, location, quality, and character of their GI symptoms, along with relevant comorbidities, family history, and alarm features. The system then automatically "translates" the patient report into a full narrative HPI available for use by GI providers in an EHR.
In a cross-sectional study in the American Journal of Gastroenterology comparing AEGIS versus physician-documented HPIs, investigators found that blinded physician reviewers perceived that AEGIS HPIs were of higher overall quality, better organized, and more succinct, comprehensible, complete and useful compared to HPIs written by physicians during usual care in academic GI clinics. In the current study, investigators aim to evaluate computer-generated HPIs prospectively on a wider scale in diverse academic and community-based settings. Moreover, investigators aim to test an enhanced AEGIS intervention that ties patient HPIs to an individualized "education prescription" which guides the patient through a library of multi-media educational materials on GI symptoms, conditions, and treatments.
Conditions
- Abdominal Pain
- Deglutition Disorders
- Fecal Incontinence
- Nausea
- Diarrhea
- Constipation
- Gastroesophageal Reflux
Interventions
- OTHER
-
AEGIS (Automated Evaluation of Gastrointestinal Symptoms)
AEGIS (Automated Evaluation of Gastrointestinal Symptoms) guides patients through questionnaires to measure symptom attributes including the timing, severity, frequency, location, quality, and character of their gastrointestinal (GI) symptoms, along with relevant comorbidities, family history, and alarm features. This information is transformed into a history of present illness (HPI) written in language familiar to clinicians. AEGIS also supports both the clinician and patient with an individualized "education prescription" which guides the patient through a library of multi-media educational materials on GI symptoms, conditions, and treatments. The prescription is created by the portal based on each patient's unique AEGIS "fingerprint."
Sponsors & Collaborators
-
Cedars-Sinai Medical Center
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-04-10
- Primary Completion
- 2018-02-07
- Completion
- 2018-02-07
Countries
- United States
Study Locations
More Related Trials
-
Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD
NCT00524355 ·Status: COMPLETED
-
Decision Aid for Gastroesophageal Reflux Disease Management
NCT01641887 ·Status: UNKNOWN
-
Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt
NCT01635959 ·Status: COMPLETED
-
A New System for GERD Diagnosis and Treatment
NCT03600974 ·Status: UNKNOWN
-
A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience
NCT01043185 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study
NCT00235677 ·Status: COMPLETED ·Phase: PHASE3
-
Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343)
NCT00336219 ·Status: COMPLETED ·Phase: PHASE3
-
Can We Predict Who Has Gastroesophageal Reflux Disease (GERD)?
NCT01204931 ·Status: COMPLETED
-
Diagnostic Yield of Post PRandial Esophageal High Resolution Impedance Manometry in Patients With Gastro-Esophageal Reflux Disease Symptoms Resistant to Proton Pump Inhibitor Therapy
NCT03596476 ·Status: RECRUITING ·Phase: NA
-
Prospective Evaluation of PH-impedance Tracings According to the Wingate Consensus, and Influence on GERD Classification According to the Lyon Consensus
NCT06084572 ·Status: RECRUITING
-
Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use
NCT00691171 ·Status: COMPLETED
-
Clinical Utility of WATS3D: A 5-Year Prospective Study
NCT04312633 ·Status: RECRUITING
-
Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease
NCT00260572 ·Status: ACTIVE_NOT_RECRUITING
-
Precision Approach to PPI Therapy in Gastroesophageal Reflux Disease
NCT03619811 ·Status: COMPLETED ·Phase: NA
-
Image-Enhanced Endoscopy (IEE) for Diagnosis of Non-Erosive Reflux Disease
NCT02629081 ·Status: COMPLETED
-
Mechanisms Preventing Pharyngeal Reflux
NCT05696184 ·Status: RECRUITING ·Phase: NA
-
Predictive Value of Subjective and Objective Measurement Tools for Extraesophageal Reflux
NCT01829074 ·Status: UNKNOWN
-
A Cross-sectional Study on the Prevalence and Extraesophageal Symptoms of Gastroesophageal Reflux Disease(GERD) in Patients With Upper GI Symptoms, Visiting the Outpatient Departments of Peripheral Hospitals in Greece
NCT01215305 ·Status: COMPLETED
-
Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients
NCT00394472 ·Status: COMPLETED ·Phase: PHASE2
-
Measurement of Gastric Secretion by MRI Under Inhibition by ProtonPump Inhibitors in Healthy Subjects & in GERD Patients
NCT01212614 ·Status: COMPLETED ·Phase: NA
-
Impact of GERD on Daily Life (NIS)
NCT00545883 ·Status: COMPLETED
-
CEGIR 7807: Validation of Online Cohort of EGID Patients Enrolled in RDCRN CEGIR Contact Registry
NCT03382678 ·Status: COMPLETED
-
Correlates of GERD Symptom Severity
NCT03020550 ·Status: COMPLETED
-
Assessment of Esophageal Epithelium Integrity With Mucosal Impedance
NCT02318862 ·Status: COMPLETED ·Phase: NA
-
Digma System First in Human (FIH) Study
NCT07331857 ·Status: NOT_YET_RECRUITING ·Phase: NA